NCT06659406

Effect of Coenzyme Q10 Administration on Polycystic Ovary Syndrome

The Effect of Coenzyme Q10 Supplementation on Oxidative Stress, Inflammation and Hyperandrogenism in Women with Polycystic Ovary Syndrome

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University of Faisalabad · Academic / Other
• Sex: Female
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to determine the effects of coenzyme Q10 supplementation on oxidative stress, inflammation and hyperandrogenism in women with polycystic ovary syndrome. The main questions it aims to answer are: Does Coenzyme Q10 alter oxidative stress, inflammation and hyperandrogenism in women with Polycystic ovary syndrome. Participants will take Coenzyme Q10 200mg, once daily for a period of 3 months. The participants will be reassessed after 12 weeks by measuring Malondialdehyde MDA, C-reactive protein CRP, Sex hormone binding globulin SHBG.

Conditions

• Polycystic Ovarian Syndrome (PCOS)

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Coenzyme Q10	Coenzyme Q10 will be given once daily, 200mg for the period of 3 months

Timeline

• Start date: 2025-01-01
• Primary completion: 2025-04-01
• Completion: 2025-12-01
• First posted: 2024-10-26
• Last updated: 2024-10-26

Locations

1 site across 1 country: Pakistan